Hester Biosciences Limited — Others, 13-08-2025: Shareholders meeting

Hester Biosciences shareholders have overwhelmingly approved all six resolutions at the 38th Annual General Meeting. This includes the adoption of the company's audited standalone and consolidated financial statements for the past fiscal year, and the declaration of a dividend on equity shares. Key governance items were also passed, such as the re-appointment of Dr. Bhupendra Gandhi as a Director, the appointment of the Secretarial Auditor, and the ratification of the Cost Auditors' remuneration. This strong shareholder mandate reinforces the company's operational direction and financial transparency.